コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 erference with the virus docking to the host cell receptor.
2 omplexes including the CD19 subunit of the B-cell receptor.
3 een anti-CD20 antibodies and lymphoma cancer cell receptors.
4 ood samples to interact with lymphoma cancer cell receptors.
5 many cancers are not fully recognized via NK cell receptors.
6 specific glycan determinants exposed on host cell receptors.
7 nstant alpha and beta domains of the human T-cell receptor, a technology known as bispecific engageme
8 n BTN3A1 inhibits tumor-reactive alphabeta T cell receptor activation by preventing segregation of N-
11 g the roles of B cell precursor frequency, B cell receptor affinity for antigen, antigen avidity, and
13 l TCRs (e.g., immune-mobilizing monoclonal T cell receptors against cancer [ImmTAC] molecules), where
15 ntra- and inter-method reproducibility for T cell receptor alpha (TRA) and T cell receptor beta (TRB)
16 based single-cell RNA sequencing of paired T cell receptor alpha and beta chain sequences show pronou
17 staining and coexpression of CD161 and the T-cell receptor alpha variable gene TRAV1-2 were strongly
18 es of immunoglobulin H (IgH), Igkappa, and T cell receptor-alpha (TCRalpha) loci during B lymphopoies
20 es of immune cells, coupled with assembled T cell receptor and B cell receptor sequences, we analyzed
21 thways affected in these disorders include T cell receptor and B cell receptor signaling, cytokine si
22 s solely responsible for binding to the host cell receptor and facilitating fusion between the viral
24 g of automatically prepared libraries from T-cell receptor and immunoglobulin gene rearrangements in
25 le, transcriptional activation of both the T-cell receptor and programmed cell death protein 1 pathwa
27 e cell therapy, including chimeric antigen T-cell receptors and other novel T-cell receptor-based the
29 y low frequencies of appropriate precursor B cell receptors and the complex maturation pathways requi
30 on, such as the targeting of pathways for NK cell receptors and their ligands, apoptosis, and cytokin
31 ction between its Spike protein and the host cell receptor angiotensin-converting enzyme 2 (ACE2).
32 , but OT1 mice fail to do so because their T cell receptors are engineered to recognize a single oval
34 ands for stimulation and co-stimulation of T-cell receptors are presented via the fluid, synthetic me
35 amily tyrosine kinase (LYN), zeta chain of T-cell receptor-associated protein kinase 70 (ZAP-70), and
37 raction; and (2) limiting the amount of stem cell receptors available for niche signal reception.
40 F) and next-generation sequencing of B and T cell receptor (BCR and TCR) repertoires, we demonstrate
41 repository of currently >14 million B and T cell receptor (BCR and TCR) sequences from the blood of
43 he antigen-binding variable regions of the B cell receptor (BCR) and of antibodies are encoded by exo
47 2A (LMP2A), which has been described as a B cell receptor (BCR) mimic promoting malignant transforma
53 ame initial V(D)J rearrangement, but their B cell receptor (BCR) sequence may differ due to the accum
55 lymphoma cell proteins and inhibits early B-cell receptor (BCR) signaling events critical for surviv
57 , PKCbetaI and PKCbetaII, functions in the B cell receptor (BCR) signaling pathway and contributes to
59 re B lineage selection have been linked to B cell receptor (BCR) signaling strength and environmental
60 d PI3K signaling consistent with activated B cell receptor (BCR) signaling, although they do not expr
63 ncreasingly used to query the antibody, or B-cell receptor (BCR), sequence repertoire, and the amount
64 from that of conventional B cells, through B cell receptor (BCR)-dependent positive selection of feta
68 to external signals, such as in binding of B cell receptors (BCR) to antigen, which initiates signali
69 rface of an antigen-presenting cell (APC), B cell receptors (BCRs) are gathered into microclusters th
70 Animal models of human antigen-specific B cell receptors (BCRs) generally depend on "inferred germ
71 alk between Toll-like receptors (TLRs) and B cell receptors (BCRs) in the TI B cell immunity, we here
72 h affinity antibodies, the soluble form of B cell receptors (BCRs), that bind to and neutralize invad
74 ency, which prompted us to investigate the T cell receptor beta (TCRbeta) repertoire in the CP and co
80 ociated with oligoclonality and restricted T-cell receptor beta-chain V-J pairing in CD8(+) but not C
82 class T epitope on SEB overlapped with the T-cell receptor binding site, whereas other evidence sugge
83 I complex stability, beta167-169 RGD loop, T-cell receptor binding, formation of homodimer of alpha-b
84 rcinoma (RCC) tumors were stained for the NK cell receptors CD56, NKp30, and NKp46 to determine expre
90 rearranged Igh allele assembles into a PreB cell receptor complex (PreBCR) to generate signals to in
91 round anchor pockets 1 and 9, as potential T-cell receptor contacts, in the areas for CD4 binding and
93 east 91 unique clones expressing different T-cell receptors) directed against HLA*02:01-restricted pe
98 ior in mice and was partially dependent on T cell receptor engagement and commensal-derived signals.
99 hed, control C57BL/6 mouse LNSC suppressed T-cell receptor engagement by anti-CD3/CD28 via MHC-indepe
100 recombinant CHIKV strain encoding a CD8(+) T cell receptor epitope from ovalbumin, as well as a viral
101 ototypical celiac patient-derived anti-TG2 B cell receptor equally reactive to human and mouse TG2.
103 ed TCR V-beta repertoire usage and diluted T-cell receptor excision circles confirm that DN T cells f
107 cile infection showed increased IL-17A and T cell receptor gamma chain expression, and IL-17 producti
108 but molecular testing identified the same T-cell receptor gamma rearrangement present in the gastric
110 unctional avidity of selected gamma9delta2 T cell receptors (gamma9delta2TCRs), was not associated wi
111 rase chain reaction-based investigation of T-cell receptor gene rearrangement to detect clonality.
112 le possess the most diverse repertoire of NK cell receptor genes among all mammals studied to date.
113 ll clones through paired sequencing of the T cell receptor genes and high-dimensional single-cell spa
115 mbination assembles and diversifies Ig and T cell receptor genes in developing B and T lymphocytes.
117 a background of high genetic diversity of NK cell receptor genes, this KLRA allele fixation points to
118 ation critically enhanced signaling by the T cell receptor in the formation of functional immune syna
120 al-transduction protein STAT5)(2-4) or pre-B-cell receptors in more mature cells (via activation of t
121 ing deep single-cell sequencing of RNA and T cell receptors in patients with different types of cance
122 iles of various populations of T cells and T cell receptors in tumours, normal adjacent tissue, and p
125 ll cytotoxicity and expression of certain NK cell receptors involved in NK cell development and funct
126 The effectiveness of pathogen detection by T cell receptor is limited by chemical similarity of forei
128 design of effective immunogens to activate B cell receptors leading to protective HIV-1 antibodies wi
129 reach the stationary concentration of the T-cell-receptor-ligand-activated complex, which transfers
130 in and residues involved in binding the host-cell receptor, lipolysis-stimulated lipoprotein receptor
132 y triggers that can enhance or even bypass T cell receptor-mediated signals-substantially broadening
133 can, in principle, be discovered against any cell receptors; moreover, the aptamers can be replaced b
134 ILCs was not dependent on the natural killer cell receptor (NCR1), since NCR1-deficient mice still in
135 were generated that bridge the activating NK cell receptor NKp30 on NK cells with epidermal growth fa
136 napse is classically described between the T-cell receptor of CD4-positive lymphocytes and MHC II on
140 ng and visualizing glycans and protein-based cell receptors overexpressed in certain diseases, which
146 ination and subsequent selection of T- and B-cell receptors provide useful tools to analyse and compa
148 UC) using single-cell transcriptomics with T-cell receptor repertoire analysis and mass cytometry.
149 se, profound immune exhaustion with skewed T cell receptor repertoire and broad T cell expansion.
152 l carcinomas and correlated metrics of the T-cell receptor repertoire with clinicopathologic characte
153 mmune-monitoring reveals remodeling of the T-cell receptor repertoire with immunodominant clones and
154 ansport into the endoplasmic reticulum and T-cell receptor repertoire, also contribute to the immunog
158 ability to induce c-Jun/AP-1 expression on T cell receptor restimulation, a mechanism that may contri
159 e-like T cells expressing a semi-invariant T cell receptor restricted to the non-classical MHC class
162 coupled with assembled T cell receptor and B cell receptor sequences, we analyzed the functional prop
164 tical modeling and statistical analyses of T cell receptor sequencing data, we develop a quantitative
166 nrichment of immune-related processes, and T cell receptor sequencing revealed increased clonality in
167 umors, we conducted whole genome, RNA, and T-cell receptor sequencing, immunohistochemistry and rever
168 Previous studies suggested that chronic B-cell receptor signaling and increased NF-kappaB activati
169 re, we review the current understanding of T-cell receptor signaling and their intersection with IC s
170 t activates the PI3K pathway downstream of B cell receptor signaling in B cells and Toll-like recepto
171 lve the spatial and temporal resolution of T cell receptor signaling in the context of immune respons
172 mphoma-2, and inhibitors of kinases in the B-cell receptor signaling pathway, like Bruton tyrosine ki
173 Unique attached oligomannoses activate B-cell receptor signaling pathways after engagement with c
174 er, the relative contributions of IL-2 and T cell receptor signaling to this process are unknown.
176 isingly, NFAT activation is independent of B-cell receptor signaling, but mediated by an increased ca
177 hese disorders include T cell receptor and B cell receptor signaling, cytokine signaling, skin barrie
178 yrosine phosphosites that mediate proximal T cell receptor signaling, cytoskeletal organization, and
179 cellular processes, including deregulated B cell receptor signaling, which we also identified in hum
187 biting T cell proliferation in response to T cell receptor stimulation and mediating fibroblast cell
189 in TILs was induced by the coordination of T cell receptor stimulation, microenvironmental stressors
193 iencies received 155 mismatched grafts: 30 T-cell receptor (TCR) alphabeta/CD19-depleted grafts, 43 c
194 nalyzing the cytokine production following T cell receptor (TCR) and co-receptor stimulation with a c
195 vation by enabling interaction between the T-cell receptor (TCR) and human leukocyte antigen class II
199 t a subpopulation of T cells expresses two T cell receptor (TCR) clonotypes, though the extent and fu
201 -23)) specificity, and mutation of the key T-cell receptor (TCR) contact residue within the epitope p
202 eptide elution, mixed lymphocyte reaction, T-cell receptor (TCR) deep sequencing, tetramer-guided nai
204 ive selection in the thymus when their new T cell receptor (TCR) engages and signals in response to s
205 and clonality index of T cells by means of T-cell receptor (TCR) immunosequencing in a discovery data
208 cell maturation and activation depend upon T cell receptor (TCR) interactions with a wide variety of
209 Mechanosensing by T cells through the T cell receptor (TCR) is at the heart of immune recognitio
210 eric antigen receptor (CAR) or a classical T cell receptor (TCR) is revolutionizing cancer treatment,
211 to study OT-1 T cells, revealing that the T cell receptor (TCR) mechanically samples antigens carryi
213 mediated immunity is governed primarily by T cell receptor (TCR) recognition of peptide-human leukocy
214 CRISPR-Cas9 screening to establish that a T cell receptor (TCR) recognized and killed most human can
216 TILs, TSA-reactive TILs possess a distinct T cell receptor (TCR) repertoire and unique gene features.
217 spond to nickel but the involved alphabeta T cell receptor (TCR) repertoire has not been comprehensiv
219 clone size distribution of the human naive T-cell receptor (TCR) repertoire is an important determina
221 rted by a combination of immunophenotypic, T cell receptor (TCR) repertoire, functional, and transcri
224 peptidome variation contributes to shaping T cell receptor (TCR) repertoires and hence individual imm
231 ude selecting an appropriate repertoire of T cell receptor (TCR) self-affinities in the thymus, regul
233 th a substantial increase in the number of T-cell receptor (TCR) sequences and their cognate antigens
234 e utilized the complementary approaches of T cell receptor (TCR) sequencing and cytometry by time-of-
235 e assessed with single-cell RNA and paired T cell receptor (TCR) sequencing of 30,604 T cells from 7
236 rein, we perform genome-wide DNA, RNA, and T cell receptor (TCR) sequencing on 29 cutaneous gammadelt
237 Transcriptional profiling coupled with T cell receptor (TCR) sequencing reveal lineage connection
238 this issue of the JCI, Ogongo et al. used T cell receptor (TCR) sequencing to characterize unconvent
242 ified an interaction between Trib1 and the T cell receptor (TCR) signaling activator, MALT1, which di
243 It is known that antigen recognition and T cell receptor (TCR) signaling depend on forces applied b
246 , single-cell RNA sequencing revealed that T cell receptor (TCR) signalling was enhanced in these cel
247 cardiac autoantigen and that T cells with T cell receptor (TCR) specificity to MYHCA acquired a Treg
250 tegrates signal strength downstream of the T cell receptor (TCR) within activated thymocytes and peri
251 we report that, similar to the endogenous T cell receptor (TCR), antigen engagement triggers the for
252 through multiple receptors, including the T-cell receptor (TCR), co-receptors, and cytokine receptor
255 e Qa-1, which disrupts Qa-1 binding to the T cell receptor (TCR)-CD8 complex and impairs the CD8 Treg
256 adelta T cell population that respond in a T cell receptor (TCR)-dependent manner to phosphoantigens
257 votal regulators of immune tolerance, with T cell receptor (TCR)-driven activated T reg (aT reg) cell
258 zens of unique barcoded templates into the T cell receptor (TCR)-locus revealed gene constructs that
259 g., virus-infected cells, which depends on T cell receptor (TCR)-mediated activation of beta(2)-integ
264 olecular modeling, we established that the T cell receptor (TCR):CD3 complex is required for USSN-ind
266 eering chimeric antigen receptors (CAR) or T cell receptors (TCR) helps create disease-specific T cel
269 the binding of pathogenic superantigens to T cell receptors (TCRs) and/or major histocompatibility co
271 lls engineered to express antigen-specific T cell receptors (TCRs) are potent therapies for viral inf
273 stocompatibility complex (pMHC) ligand for T cell receptors (TCRs) is inactive from solution yet capa
275 iation (CD)8(+) T cells, by means of their T cell receptors (TCRs) recognizing intracellular targets
276 cultured T cells expressing MCPyV-specific T cell receptors (TCRs) show increased cytokine production
277 of Vdelta1, three CD1b-specific gammadelta T cell receptors (TCRs) showed clear differences in the su
280 hreats in an antigen-specific manner using T cell receptors (TCRs) that recognize short peptide antig
281 y described GLIPH, an algorithm to cluster T-cell receptors (TCRs) that recognize the same epitope an
282 distinctive nature of DURTs and gammadelta T cell receptors (TCRs) to investigate the involvement of
284 High-avidity CBFB-MYH11 epitope-specific T cell receptors (TCRs) transduced into CD8+ T cells confe
286 the associations of particular gammadelta T cell receptors (TCRs) with specific anatomical sites.
287 neered T cells expressing antigen-specific T-cell receptors (TCRs), is an appealing therapeutic appro
291 red for N-glycosylation of key T cell and NK cell receptors that can account for some of the clinical
292 (MHC) class I, MHC class II and alphabeta T cell receptors, the antigenic specificity of the gammade
294 mented expression of CEACAM1 and ICAM1, host cell receptors to which NTHI binds via engagement of mul
298 ed erythrocytes bind to specific endothelial cell receptors via members of the PfEMP1 family exported
299 es such as IFNA, MRC1, immunoglobulins and T-cell receptors which contribute to defend against pathog
300 ic strategy combining an affinity-enhanced T Cell receptor with an anti-CD3 T Cell-activating moiety.